ישראל -
עברית -
Ministry of Health
אורפיריל זריקה
megapharm ltd - valproic acid as sodium - תמיסה להזרקה\אינפוזיה - valproic acid as sodium 300 mg / 3 ml - valproic acid - valproic acid - treatment of generalized seizures in the form of absence, myoclonic and tonic-clonic seizures and partial and secondary generalized seizures.
ישראל -
עברית -
Ministry of Health
דפלפט כרונו 500 מ"ג
cts chemical industries ltd - valproic acid 145 mg; valproic acid as sodium 333 mg - tablets slow release - valproic acid - treatment of generalized or partial epilepsy secondary epilepsy and mixed forms of epilepsy. bipolar disorders: treatment and/or prevention of acute manic episodes in the context of bipolar disorders.
ישראל -
עברית -
Ministry of Health
סברילן
padagis israel pharmaceuticals ltd, israel - vigabatrin - טבליות מצופות פילם - vigabatrin 500 mg - vigabatrin - vigabatrin - treatment in combination with other anti epileptic drugs for patients with resistant partial epilepsy with or without secondary generalisation, that is where all other appropriate drug combinations have proven inadeqate or have not been tolerated.
ישראל -
עברית -
Ministry of Health
דפלפט תמיסה
cts chemical industries ltd, israel - valproic acid as sodium - תמיסה (פומי) - valproic acid as sodium 200 mg/ml - valproic acid - treatment of generalized or partial epilepsy secondary generalized epilepsy and mixed forms of epilepsy.
ישראל -
עברית -
Ministry of Health
דפלפט כרונו 500 מג
sanofi - aventis israel ltd - valproic acid; valproic acid as sodium - טבליות בשחרור ממושך - valproic acid 145 mg; valproic acid as sodium 333 mg - valproic acid
ישראל -
עברית -
Ministry of Health
דפלפט כרונו 500 מג
sanofi israel ltd - valproic acid; valproic acid as sodium - טבליות בשחרור ממושך - valproic acid 145 mg; valproic acid as sodium 333 mg - valproic acid
ישראל -
עברית -
Ministry of Health
סודיום ואלפרואט ווקהרט
propharm ltd - valproic acid as sodium - תמיסה להזרקה\אינפוזיה - valproic acid as sodium 100 mg/ml - valproic acid
ישראל -
עברית -
Ministry of Health
יאז פלוס
bayer israel ltd - drospirenone; ethinylestradiol as betadex clathrate; levomefolate calcium; levomefolate calcium - טבליות מצופות פילם - levomefolate calcium 0.451 mg; ethinylestradiol as betadex clathrate 0.02 mg; drospirenone 3 mg; levomefolate calcium 0.451 mg - estradiol, combinations
ישראל -
עברית -
Ministry of Health
פגסיס 135 מק"ג/0.5 מ"ל
roche pharmaceuticals (israel) ltd - peginterferon alfa 2a 135 mcg / 0.5 ml - solution for injection - peginterferon alfa-2a - chronic hepatitis b: pegasys is indicated for the treatment of both hbeag- positive and hbeag -negative chronic hepatitis b in non-cirrhotic and cirrhotic adult patients with compensated liver disease and evidence of viral replication and liver inflammation.chronic hepatitis c: pegasys is indicated for the treatment of chronic hepatitis c in adult patients who are positive for serum hcv-rna including patients with compensated cirrhosis and/or co-infected with clinically stable hiv. the optimal way to use pegasys in patients with chronic hepatitis c is in combination with ribavirin. the combination of pegasys and ribavirin is indicated in naive patients and patients who have failed previous treatment with interferon alpha (pegylated or non-pegylated ) alone or in combination therapy with ribavirin. monotherapy is indicated mainly in case of intolerance or contraindication to ribavirin.